Expression of functional CD40 by vascular endothelial cells - PubMed (original) (raw)
Expression of functional CD40 by vascular endothelial cells
D Hollenbaugh et al. J Exp Med. 1995.
Abstract
The interaction between activated vascular endothelium and T cells has been shown to play an important role in the recruitment and activation of T cells at sites of inflammation. Here we report the expression of CD40 by vascular endothelial cells and its regulation by inflammatory agents. Using the soluble recombinant CD40 ligand, sgp39, we show that the interaction of CD40 with its ligand can lead to endothelial cell activation, which in turn leads to leukocyte adhesion. This adhesion is partly mediated by the expression of E-selectin. In addition to E-selectin expression, sgp39 induces the expression of intercellular adhesion molecule 1 and augments the tumor necrosis factor alpha-induced expression of vascular cell adhesion molecule 1. The effects of sgp39 on endothelial cells can be blocked with anti-gp39 monoclonal antibody (mAb), anti-CD40 mAb, or soluble CD40. Staining of tissues from healthy human skin using anti-CD40 mAb showed very weak expression of CD40 by the endothelium, while skin involved in inflammatory disease showed marked upregulation of CD40 expression. These studies suggest that interactions between cell surface proteins expressed by activated T cells with their receptors on vascular endothelium can stimulate the vasculature at sites of inflammation and may be involved in normal inflammatory responses and in inflammatory disease.
Similar articles
- CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.
Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. Karmann K, et al. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4342-6. doi: 10.1073/pnas.92.10.4342. Proc Natl Acad Sci U S A. 1995. PMID: 7538666 Free PMC article. - Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L. Yellin MJ, et al. J Exp Med. 1995 Dec 1;182(6):1857-64. doi: 10.1084/jem.182.6.1857. J Exp Med. 1995. PMID: 7500031 Free PMC article. - Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation.
Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L. Yellin MJ, et al. J Leukoc Biol. 1995 Aug;58(2):209-16. doi: 10.1002/jlb.58.2.209. J Leukoc Biol. 1995. PMID: 7543921 - Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules.
Nakanuma Y, Yasoshima M, Tsuneyama K, Harada K. Nakanuma Y, et al. Semin Liver Dis. 1997 Feb;17(1):35-47. doi: 10.1055/s-2007-1007181. Semin Liver Dis. 1997. PMID: 9089909 Review. - Current views on structure and function of endothelial adhesion molecules.
Stad RK, Buurman WA. Stad RK, et al. Cell Adhes Commun. 1994 Jul;2(3):261-8. doi: 10.3109/15419069409004446. Cell Adhes Commun. 1994. PMID: 7530152 Review. No abstract available.
Cited by
- Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice.
Ingoglia G, Yalamanoglu A, Pfefferlé M, Dubach IL, Schaer CA, Valkova K, Hansen K, Schulthess N, Humar R, Schaer DJ, Vallelian F. Ingoglia G, et al. Blood Adv. 2020 Jun 23;4(12):2751-2761. doi: 10.1182/bloodadvances.2020001624. Blood Adv. 2020. PMID: 32559293 Free PMC article. - TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.
Nakabayashi T, Sakata KM, Sakata A, Kong L, Lau CA, Letterio JJ, Vela-Roch N, Talal N, Dang H. Nakabayashi T, et al. Inflammation. 2001 Apr;25(2):69-73. doi: 10.1023/a:1007158219974. Inflammation. 2001. PMID: 11321361 - Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.
Zhou HJ, Pham LV, Tamayo AT, Lin-Lee YC, Fu L, Yoshimura LC, Ford RJ. Zhou HJ, et al. Blood. 2007 Sep 15;110(6):2121-7. doi: 10.1182/blood-2007-02-073080. Epub 2007 Jun 13. Blood. 2007. PMID: 17567982 Free PMC article. - CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation.
Singh AK, Goerlich CE, Zhang T, Lewis BGT, Hershfeld A, Mohiuddin MM. Singh AK, et al. Transplantation. 2023 Jul 1;107(7):1472-1481. doi: 10.1097/TP.0000000000004469. Epub 2023 Jun 20. Transplantation. 2023. PMID: 36584382 Free PMC article. Review. - New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5).
Piechutta M, Berghoff AS. Piechutta M, et al. ESMO Open. 2019 Jun 12;4(Suppl 3):e000510. doi: 10.1136/esmoopen-2019-000510. eCollection 2019. ESMO Open. 2019. PMID: 31275618 Free PMC article. Review.
References
- Transplantation. 1991 Feb;51(2):537-9 - PubMed
- J Cell Biol. 1995 Feb;128(4):687-98 - PubMed
- Cancer Immunol Immunother. 1985;20(1):23-8 - PubMed
- Proc Natl Acad Sci U S A. 1986 Jun;83(12):4494-8 - PubMed
- J Immunol. 1987 Feb 1;138(3):788-94 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials